Skip to content

AngioDynamics ANGO Price / earnings

Price / earnings at other companies

Abbott logo
AbbottABT
28.4×+11.4×
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
39.3×-4.6×
TFX
TeleflexTFX
27.7×-9.9×
Stryker logo
StrykerSYK
37.7×-12.0×
Merit Medical Systems logo
Merit Medical SystemsMMSI
29.4×-21.5×
Boston Scientific logo
Boston ScientificBSX
26.2×-47.5×

Other financials

Income statement

See full
Revenue$78.4M+8.9%
Gross profit$41.5M+6.7%
Operating income-$13.0M-29.8%
Net income-$8.1M-83.4%
EPS (diluted)-$0.19-72.7%

Balance sheet

See full
Cash & equivalents$37.8M-15.5%
Total debt$7.9M+10.2%
Total equity$173.4M-6.7%
Total assets$260.7M-8.7%

Cash flow

See full
Operating cash flow-$3.1M+76.4%
CapEx$1.0M-43.5%
Free cash flow-$4.1M+72.4%

Valuation

See full
Market cap$564.42M+38.7%
Enterprise value$534.51M+48.0%
P/S1.8×+0.4×

Profitability

See full
Gross margin54.3%-0.1pp
Operating margin-11.3%-2.9pp
Net margin-10%-2.4pp
FCF margin5.5%

Returns & leverage

See full
Return on equity-17.5%-2.2pp
Debt / equity0.0×
Current ratio2.4×+0.1×

Where this comes from

Calculated from AngioDynamics’s reported figures.

Based on the most recent quarter.

The official record: AngioDynamics’s 10-Q, filed October 5, 2023, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AngioDynamics's price / earnings?
AngioDynamics (ANGO) reported price / earnings of 49.4× in Q2 2023.
What does price / earnings mean?
Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.